Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Bangsberg

Showing results (1-10 of 390) with videos related to

Pageof 39
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppressionDavid R Bangsberg
The Journal of Infectious Diseases|June 14, 2008
Preventing HIV antiretroviral resistance through better monitoring of treatment adherenceDavid R Bangsberg
Current HIV/AIDS Reports|February 20, 2016
Cascade of Refusal-What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?Ingrid T Katz, David R Bangsberg
The AIDS Reader|February 6, 2007
Seven steps to better adherence: a practical approach to promoting adherence to antiretroviral therapyEdward L Machtinger, David R Bangsberg
Antiviral Therapy|January 30, 2013
Long-term adherence to antiretroviral therapy in resource-limited settings: a bitter pill to swallowDavid R Bangsberg, Edward J Mills
AIDS (London, England)|June 12, 2003
Doubts about DOT: antiretroviral therapy for resource-poor countriesCheryl A Liechty, David R Bangsberg
BMC Public Health|May 7, 2013
Alcohol use and HIV serostatus of partner predict high-risk sexual behavior among patients receiving antiretroviral therapy in South Western UgandaFrancis Bajunirwe, David R Bangsberg, Ajay K Sethi
Journal of Global Health|April 6, 2018
Quantifying bias in measuring insecticide-treated bednet use: meta-analysis of self-reported vs objectively measured adherencePaul J Krezanoski, David R Bangsberg, Alexander C Tsai
The Journal of Antimicrobial Chemotherapy|March 27, 2004
Paradoxes of adherence and drug resistance to HIV antiretroviral therapyDavid R Bangsberg, Andrew R Moss, Steven G Deeks
AIDS (London, England)|June 12, 2003
Adherence is not a barrier to successful antiretroviral therapy in South AfricaCatherine Orrell, David R Bangsberg, Motasim Badri, et al.
Pageof 39

Showing results (1-10 of 390) with videos related to

Sort By:
Pageof 39
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppressionDavid R Bangsberg
The Journal of Infectious Diseases|June 14, 2008
Preventing HIV antiretroviral resistance through better monitoring of treatment adherenceDavid R Bangsberg
Current HIV/AIDS Reports|February 20, 2016
Cascade of Refusal-What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?Ingrid T Katz, David R Bangsberg
The AIDS Reader|February 6, 2007
Seven steps to better adherence: a practical approach to promoting adherence to antiretroviral therapyEdward L Machtinger, David R Bangsberg
Antiviral Therapy|January 30, 2013
Long-term adherence to antiretroviral therapy in resource-limited settings: a bitter pill to swallowDavid R Bangsberg, Edward J Mills
AIDS (London, England)|June 12, 2003
Doubts about DOT: antiretroviral therapy for resource-poor countriesCheryl A Liechty, David R Bangsberg
BMC Public Health|May 7, 2013
Alcohol use and HIV serostatus of partner predict high-risk sexual behavior among patients receiving antiretroviral therapy in South Western UgandaFrancis Bajunirwe, David R Bangsberg, Ajay K Sethi
Journal of Global Health|April 6, 2018
Quantifying bias in measuring insecticide-treated bednet use: meta-analysis of self-reported vs objectively measured adherencePaul J Krezanoski, David R Bangsberg, Alexander C Tsai
The Journal of Antimicrobial Chemotherapy|March 27, 2004
Paradoxes of adherence and drug resistance to HIV antiretroviral therapyDavid R Bangsberg, Andrew R Moss, Steven G Deeks
AIDS (London, England)|June 12, 2003
Adherence is not a barrier to successful antiretroviral therapy in South AfricaCatherine Orrell, David R Bangsberg, Motasim Badri, et al.
Pageof 39